- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medtronic to distribute CVD catheters
Catheter developer CardioVascular Dynamics of Irvine, CA, hassigned a co-distribution deal with cardiology device manufacturerMedtronic of Minneapolis. Medtronic will buy a minimum numberof CVD angioplasty catheters for global distribution for up tothree
Catheter developer CardioVascular Dynamics of Irvine, CA, has
signed a co-distribution deal with cardiology device manufacturer
Medtronic of Minneapolis. Medtronic will buy a minimum number
of CVD angioplasty catheters for global distribution for up to
three years. The catheters covered by the agreement use CVD's
focus technology, which concentrates the device's expansion energy
on a specific area of the balloon. CVD will continue to sell focus-technology-based
catheters through its own direct and indirect sales network.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
